HemaSphere (Jun 2022)

P699: REAL-LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) OR PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL): 5-YEAR-DATA FROM A BELGIAN REGISTRY

  • T. Devos,
  • V. Havelange,
  • K. Theunissen,
  • S. Meers,
  • F. S. Benghiat,
  • A. Gadisseur,
  • G. Vanstraelen,
  • H. Vellemans,
  • B. Bailly,
  • N. Granacher,
  • P. Lewalle,
  • A. De Becker,
  • K. Van Eygen,
  • M. Lejeune,
  • M. Janssen,
  • A. Triffet,
  • I. Vrelust,
  • D. Deeren,
  • D. Mazure,
  • M. Beck,
  • H. Sebti,
  • D. Selleslag

DOI
https://doi.org/10.1097/01.HS9.0000845680.44858.4f
Journal volume & issue
Vol. 6
pp. 594 – 595

Abstract

Read online

No abstracts available.